A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward

Overview

Journal Neuron

Publisher Cell Press

Specialty Neurology

Date 2019 Mar 8

PMID 30844401

Citations 233

Authors

Michael E Belloy

Valerio Napolioni

Michael D Greicius

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however, by lingering uncertainty over how to treat the quasi "monogenic" role of apolipoprotein E (APOE). The APOE4 allele is not only the strongest genetic risk factor for AD, it also affects risk for cardiovascular disease, stroke, and other neurodegenerative disorders. This review, based mostly on data from human studies, ranges across a variety of APOE-related pathologies, touching on evolutionary genetics and risk mitigation by ethnicity and sex. The authors also address one of the most fundamental question pertaining to APOE4 and AD: does APOE4 increase AD risk via a loss or gain of function? The answer will be of the utmost importance in guiding future research in AD.

Citing Articles

From Genetics to Neuroinflammation: The Impact of ApoE4 on Microglial Function in Alzheimer's Disease.

Dias D, Portugal C, Relvas J, Socodato R Cells. 2025; 14(4).

PMID: 39996715 PMC: 11853365. DOI: 10.3390/cells14040243.

Characterizing the olfaction and dementia association in the community-based ARIC study.

Shrestha S, Zhu X, Kucharska-Newton A, Yuan Y, Kamath V, Palta P Alzheimers Dement. 2025; 21(2):e14613.

PMID: 39988999 PMC: 11847982. DOI: 10.1002/alz.14613.

The impact of apolipoprotein E, type ∊4 allele on Alzheimer's disease pathological biomarkers: a comprehensive post-mortem pilot-analysis.

Wan Z, Ma T PLoS One. 2025; 20(2):e0303486.

PMID: 39913635 PMC: 11801730. DOI: 10.1371/journal.pone.0303486.

The effect of the APOE4 genotype on physiological and cognitive health in randomised controlled trials with an exercise intervention: a systematic review and meta-analysis.

Spencer F, Elsworthy R, Breen L, Bishop J, Dunleavy C, Aldred S Trials. 2025; 26(1):20.

PMID: 39828710 PMC: 11744846. DOI: 10.1186/s13063-024-08696-4.

Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.

Matsunaga A, Saito T J Atheroscler Thromb. 2025; 32(3):281-303.

PMID: 39779225 PMC: 11883201. DOI: 10.5551/jat.65393.

References

Shinohara M, Petersen R, Dickson D, Bu G . Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation. Acta Neuropathol. 2013; 125(4):535-47. PMC: 3612369. DOI: 10.1007/s00401-013-1086-9. View

Saura J, Petegnief V, Wu X, Liang Y, Paul S . Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide. J Neurochem. 2003; 85(6):1455-67. DOI: 10.1046/j.1471-4159.2003.01788.x. View

Duggan A, Callard I . Phylogenetic distribution of apolipoproteins A-I and E in vertebrates as determined by Western blot analysis. J Exp Zool. 2001; 290(3):255-64. DOI: 10.1002/jez.1056. View

Rinaldi C, Wood M . Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol. 2017; 14(1):9-21. DOI: 10.1038/nrneurol.2017.148. View

McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

Renton A, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs J . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72(2):257-68. PMC: 3200438. DOI: 10.1016/j.neuron.2011.09.010. View

Kim J, Basak J, Holtzman D . The role of apolipoprotein E in Alzheimer's disease. Neuron. 2009; 63(3):287-303. PMC: 3044446. DOI: 10.1016/j.neuron.2009.06.026. View

Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C . Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45(12):1452-8. PMC: 3896259. DOI: 10.1038/ng.2802. View

Velez J, Lopera F, Sepulveda-Falla D, Patel H, Johar A, Chuah A . APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease. Mol Psychiatry. 2015; 21(7):916-24. PMC: 5414071. DOI: 10.1038/mp.2015.177. View

10.

Halliday M, Rege S, Ma Q, Zhao Z, Miller C, Winkler E . Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. J Cereb Blood Flow Metab. 2015; 36(1):216-27. PMC: 4758554. DOI: 10.1038/jcbfm.2015.44. View

11.

Cairns N, Atkinson P, Kovacs T, Lees A, Daniel S, Lantos P . Apolipoprotein E e4 allele frequency in patients with multiple system atrophy. Neurosci Lett. 1997; 221(2-3):161-4. DOI: 10.1016/s0304-3940(96)13316-4. View

12.

Rasmussen K . Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review. Atherosclerosis. 2017; 255:145-155. DOI: 10.1016/j.atherosclerosis.2016.10.037. View

13.

Bour A, Rasquin S, Baars L, van Boxtel M, Visser P, Limburg M . The effect of the APOE-epsilon4 allele and ACE-I/D polymorphism on cognition during a two-year follow-up in first-ever stroke patients. Dement Geriatr Cogn Disord. 2010; 29(6):534-42. DOI: 10.1159/000314678. View

14.

OBrien J, Thomas A . Vascular dementia. Lancet. 2015; 386(10004):1698-706. DOI: 10.1016/S0140-6736(15)00463-8. View

15.

Bretsky P, Buckwalter J, Seeman T, Miller C, Poirier J, Schellenberg G . Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord. 1999; 13(4):216-21. DOI: 10.1097/00002093-199910000-00007. View

16.

Mercuri E, Darras B, Chiriboga C, Day J, Campbell C, Connolly A . Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. N Engl J Med. 2018; 378(7):625-635. DOI: 10.1056/NEJMoa1710504. View

17.

Malloy M, Miller B, Kane J . Apolipoprotein E and neurocognitive function--in reply. JAMA Neurol. 2015; 72(4):479. DOI: 10.1001/jamaneurol.2014.4699. View

18.

Altmann A, Tian L, Henderson V, Greicius M . Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75(4):563-73. PMC: 4117990. DOI: 10.1002/ana.24135. View

19.

Pinholt M, Frederiksen J, Christiansen M . The association between apolipoprotein E and multiple sclerosis. Eur J Neurol. 2006; 13(6):573-80. DOI: 10.1111/j.1468-1331.2006.01360.x. View

20.

Shadyab A, LaCroix A . Genetic factors associated with longevity: a review of recent findings. Ageing Res Rev. 2014; 19:1-7. DOI: 10.1016/j.arr.2014.10.005. View